Latest Updates

Study

A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral Hepatic-Directed Vesicle Insulin Add-On to Oral Antidiabetic Treatment in Patients With Type 2 Diabetes Mellitus

February 27, 2014

Share this article
Study

Latest Updates

News

Press Release

Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes

View Article
Press Release

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View Article
Study

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

View Article
View All